MELANOMA BRAF V600E/K MUTATED
Clinical trials for MELANOMA BRAF V600E/K MUTATED explained in plain language.
Never miss a new study
Get alerted when new MELANOMA BRAF V600E/K MUTATED trials appear
Sign up with your email to follow new studies for MELANOMA BRAF V600E/K MUTATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study to zap resistant melanoma spots with surgery or radiation pulled before start
Disease control TerminatedThis study planned to test whether adding surgery, radiation, or electrochemotherapy could help control melanoma tumors that did not shrink with encorafenib + binimetinib combination therapy. It was designed for adults with BRAF-mutated melanoma who had been on the drugs for at l…
Matched conditions: MELANOMA BRAF V600E/K MUTATED
Phase: PHASE4 • Sponsor: SRH Wald-Klinikum Gera GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental antibody trio takes on Hard-to-Treat melanoma
Disease control OngoingThis early-phase trial tests a new experimental antibody called BI-1607 alongside two existing immunotherapies (ipilimumab and pembrolizumab) in 35 people with advanced melanoma that has spread or cannot be removed. The goal is to see if the combination is safe and can shrink tum…
Matched conditions: MELANOMA BRAF V600E/K MUTATED
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC